Profound Medical Corp. (TSX: PRN)
Canada
· Delayed Price · Currency is CAD
10.70
-0.16 (-1.47%)
Nov 20, 2024, 3:59 PM EST
Profound Medical Revenue
Profound Medical had revenue of $2.83M USD in the quarter ending September 30, 2024, with 63.89% growth. This brings the company's revenue in the last twelve months to $8.98M, up 39.35% year-over-year. In the year 2023, Profound Medical had annual revenue of $7.20M with 7.75% growth.
Revenue (ttm)
$8.98M
Revenue Growth
+39.35%
P/S Ratio
20.86
Revenue / Employee
$68.58K
Employees
131
Market Cap
263.88M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
Dec 31, 2019 | 4.17M | 1.57M | 60.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.33B |
Bausch Health Companies Inc. | 12.80B |
Curaleaf Holdings, Inc. | 1.83B |
dentalcorp Holdings Ltd. | 1.51B |
Tilray Brands, Inc. | 1.10B |
Sienna Senior Living Inc. | 867.55M |
WELL Health Technologies Corp. | 957.69M |
Cronos Group Inc. | 150.26M |
Profound Medical News
- 11 days ago - Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Q3 2024 Profound Medical Corp Earnings Call Transcript - GuruFocus
- 13 days ago - Profound Medical reports Q3 results - Seeking Alpha
- 15 days ago - Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus
- 17 days ago - Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 - GlobeNewsWire
- 4 weeks ago - Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow - GlobeNewsWire
- 5 weeks ago - Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Profound Medical to Participate in Lake Street's Best Ideas Growth Conference - Benzinga